Related Experiment Video
Updated: Jun 19, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
THE ARTIFICIAL PRODUCTION IN MAMMALIAN PLASMA OF SUBSTANCES INHIBITORY TO THE GROWTH OF CELLS
1Bacteriological Laboratory of the London Hospital, London.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Active immunity against tissue growth can be induced via intraperitoneal injections of tissue emulsions. This induced immunity is temporary, eventually leading to an anti-immunity phase, and is not specific to the injected tissue type.
Area of Science:
- Immunology
- Tissue Engineering
Background:
- Inducing active immunity is crucial for therapeutic interventions.
- Understanding tissue-specific immune responses is key to developing advanced treatments.
Purpose of the Study:
- To investigate the induction of active immunity against tissue growth using tissue emulsions.
- To characterize the duration and specificity of this induced immunity.
Main Methods:
- Intraperitoneal injections of tissue emulsions were administered.
- Immune response and duration were monitored over time.
- Specificity of the immune response was assessed against different tissue types.
Main Results:
- Active immunity to tissue growth was successfully obtained through intraperitoneal injections.
- The induced immunity was found to be of short duration, followed by a phase of anti-immunity.
- Immunity varied in extent and onset time depending on the specific tissue.
- The immune response was not specific, showing no enhanced effect against the homologous tissue.
Conclusions:
- Intraperitoneal administration of tissue emulsions can induce temporary active immunity.
- The lack of specificity suggests a generalized immune response rather than a targeted one.
- Further research is needed to understand and potentially enhance the duration and specificity of this immunity for therapeutic applications.
Related Concept Videos
Cell Culture
Most vertebrate cells grow in vitro attached to a substrate as a monolayer, called adherent cultures. The flasks and plates used to grow cells are chemically treated to facilitate cell attachment. However, a few cell types, such as hematopoietic cells, can grow in a suspension. In contrast to adherent cultures, suspension cultures can grow in non-treated cultureware using magnetic stirrers or spinner flasks to agitate the culture media
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

